How Do We Navigate the Complexities Surrounding the Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Chronic Kidney Disease?
Abstract
Blockade of the renin-angiotensin-aldosterone system (RAAS) with angiotensin-converting enzyme inhibition or angiotensin receptor blockade remains the central therapy for both renal and cardiovascular protection in patients with chronic kidney disease (CKD).1Brenner B.M. Cooper M.E. de Zeeuw D. et al.RENAAL Study InvestigatorsEffects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.N Engl J Med....
Paper Details
Title
How Do We Navigate the Complexities Surrounding the Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Chronic Kidney Disease?
Published Date
Nov 1, 2019
Journal
Volume
94
Issue
11
Pages
2166 - 2169
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History